Posts Tagged: CIRM
News
California’s $12 billion stem cell agency needs to do better in several critical areas, ranging from planning for the replacement of its current chair to handling information that is key to its operations as well as the tracking of potential sources of royalties. That’s according to that latest performance audit of the 17-year-old agency.
News
A multibillion-dollar matter was on the table when the 35-members of the governing board of the California stem cell agency huddled electronically to put together a strategy for the next five years. “Real Life” popped up during last week’s meeting along with diversity, legacies, voters, ballot measures. transformative medicine and cures.
News
Directors of the $12 billion California stem cell agency have moved to weaken conflict of interest provisions affecting its governing board — eliminating “leave-the-room” requirements that are used by most private nonprofits to assure the integrity of their operations.
News
Directors of the California stem cell agency last week handed out $2 million a minute to nearly 20 organizations during an online meeting that spread the largess from Sacramento in the north to San Diego in the south.
News
California’s taxpayer-financed stem cell agency will give away $98 million later this week, but the agency’s full, 35-member board is not going to have much to do with making decisions about who gets what. That’s because 17 members of the governing board are barred from voting on applications for any of its research awards, which will ultimately total roughly $5 billion over the next decade or so.
News
The folks in Orange Cove in California’s agriculturally rich Central Valley care about the cost of health care. It is part of their struggle each day as they try to live on $27,000 a year, the lowest median household income of any town in the Golden State. Over in Oakland at the headquarters of the $12 billion state stem cell agency, the folks there are also worried about the cost of health care, particularly cell and gene therapies that may well cost upwards of $2 million.
News
They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years.
News
A London-based biotech firm has given up its life-saving treatment for the bubble baby disease and turned it over to California’s $12 billion stem cell agency and UCLA, where it was developed with tens of millions of taxpayer dollars.
News
The story about Jakob, Sheersha and Clementine is a 6,000-mile biomedical tale that spans the Atlantic. The story ranges from the Saskatchewan River in Canada to the dusty Tehachapi mountains in drought-plagued Southern California. And it is a story of children with a terrible and rare genetic affliction known as the bubble baby disease.
News
The California stem cell agency says it is doing “everything” it can to move forward on a gene therapy that has saved the lives of more than 50 persons but which has been pushed aside by the company that has exclusive rights to it. The issue has raised questions about the ethics of withholding care from babies and children suffering from a fatal disease.
A researcher examines meat cultured in laboratory conditions from stem cells. (Photo: Alex_Traksel, via Shutterstock)
